• What is the MDR and why are Pharma products affected?
• What is new compared to before MDR
• Status on MDR implementation
• Notified body readiness
• New requirement on drug manufacturers
• Implication on combination product manufacturers / shortage of notified bodies
• Risk on drug product submissions in the EU
• EU vs US comparison on combination product regulation
• What is the MDR and why are Pharma products affected?
• What is new compared to before MDR
• Status on MDR implementation
• Notified body readiness
• New requirement on drug manufacturers
• Implication on combination product manufacturers / shortage of notified bodies
• Risk on drug product submissions in the EU
• EU vs US comparison on combination product regulation
Sponsored by:
• What defines a true wearable device platform?
• Importance of container flexibility
• What is possible beyond large volume?
• DFM/DTC approach in drug delivery
• What defines a true wearable device platform?
• Importance of container flexibility
• What is possible beyond large volume?
• DFM/DTC approach in drug delivery
Sponsored by:
• What defines a true wearable device platform?
• Importance of container flexibility
• What is possible beyond large volume?
• DFM/DTC approach in drug delivery
• What defines a true wearable device platform?
• Importance of container flexibility
• What is possible beyond large volume?
• DFM/DTC approach in drug delivery
Sponsored by:
• Monitoring real-time production lines efficiency
• Optimizing performances and OEE
• Connecting serialization lines and any other equipment
• Improving resource planning and maintenance
Sponsored by:
• Monitoring real-time production lines efficiency
• Optimizing performances and OEE
• Connecting serialization lines and any other equipment
• Improving resource planning and maintenance
Sponsored by:
Drug delivery devices have taken on increasing sophistication to meet the needs of increasingly tech savvy patients. At the same time, more and more regulatory requirements such as recent revisions to USP661.1 have raised the bar for suppliers in this increasingly competitive arena. This presentation will outline and present examples of how Covestro, a polycarbonate supplier to healthcare for over 50 years, innovates its materials portfolio for healthcare to meet these challenges.
• Key Polycarbonate material properties for new Drug Delivery Devices
• Changing needs and requirements for Drug Delivery Devices (e.g. USP661.1)
• Polycarbonate innovations for Global Drug Delivery Device Manufacturers
• Orienting Drug Delivery Materials toward Circular Economies and New Sustainability Requirements
Sponsored by:
Drug delivery devices have taken on increasing sophistication to meet the needs of increasingly tech savvy patients. At the same time, more and more regulatory requirements such as recent revisions to USP661.1 have raised the bar for suppliers in this increasingly competitive arena. This presentation will outline and present examples of how Covestro, a polycarbonate supplier to healthcare for over 50 years, innovates its materials portfolio for healthcare to meet these challenges.
• Key Polycarbonate material properties for new Drug Delivery Devices
• Changing needs and requirements for Drug Delivery Devices (e.g. USP661.1)
• Polycarbonate innovations for Global Drug Delivery Device Manufacturers
• Orienting Drug Delivery Materials toward Circular Economies and New Sustainability Requirements
Sponsored by:
Understanding hospital and care center’s unmet needs is vital for providing them with impactful solutions. In the healthcare setting, patient safety concerns exist across the entire drug delivery spectrum. Specifically, in an acute care setting where decisions are often made quickly or under stress, error rates can be at their highest.
In a healthcare setting, medication errors can result from human factors, work-arounds etc. and may be linked with the type of primary container being used in medication preparation and administration. Collectively, drug delivery mistakes create challenges in maintaining optimal patient safety, healthcare worker safety, and can negatively impact the end user’s bottom line. Through the workshop, we will address how differences in primary container options for injectable drugs can add value by offering care centers configurations that address universal pain points.
Sponsored by:
Understanding hospital and care center’s unmet needs is vital for providing them with impactful solutions. In the healthcare setting, patient safety concerns exist across the entire drug delivery spectrum. Specifically, in an acute care setting where decisions are often made quickly or under stress, error rates can be at their highest.
In a healthcare setting, medication errors can result from human factors, work-arounds etc. and may be linked with the type of primary container being used in medication preparation and administration. Collectively, drug delivery mistakes create challenges in maintaining optimal patient safety, healthcare worker safety, and can negatively impact the end user’s bottom line. Through the workshop, we will address how differences in primary container options for injectable drugs can add value by offering care centers configurations that address universal pain points.
Sponsored by:
